ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts16161717
Avg. Estimate-2.07-2.07-8.5-6.85
Low Estimate-2.49-2.52-9.85-8.52
High Estimate-1.49-1.69-6.9-3.72
Year Ago EPS-1.41-1.63-7.57-8.5
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts14141717
Avg. Estimate23.58M33.84M162.16M429.5M
Low Estimate13.9M18M94M253M
High Estimate50.25M80.71M396.08M874.74M
Year Ago Sales21.9M29.91M74.91M162.16M
Sales Growth (year/est)7.70%13.20%116.50%164.90%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-1.47-1.75-1.99-2.21
EPS Actual-1.41-1.63-2.43-2.09
Difference0.060.12-0.440.12
Surprise %4.10%6.90%-22.10%5.40%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-2.07-2.07-8.5-6.85
7 Days Ago-2.11-2.1-8.52-6.77
30 Days Ago-2.11-2.14-8.69-6.96
60 Days Ago-2.13-2.16-8.76-6.85
90 Days Ago-2.17-2.15-8.06-6.02
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/A121
Up Last 30 Days1453
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A2
Growth EstimatesALNYIndustrySectorS&P 500
Current Qtr.-46.80%N/AN/A-0.02
Next Qtr.-27.00%N/AN/A0.04
Current Year-12.30%N/AN/A0.05
Next Year19.40%N/AN/A0.11
Next 5 Years (per annum)46.09%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A